Schonfeld Strategic Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Sell |
|
|||||
|
2025
Q1 | $18.6M | Buy |
|
|||||
|
2024
Q4 | $730K | Sell |
|
|||||
|
2024
Q3 | $2.15M | Sell |
|
|||||
|
2024
Q2 | $16.8M | Buy |
|
|||||
|
2024
Q1 | $15.9M | Buy |
|
|||||
|
2023
Q4 | $16.5M | Buy |
|
|||||
|
2023
Q3 | $8.41M | Buy |
|
|||||
|
2023
Q2 | $5.06M | Buy |
|
|||||
|
2023
Q1 | $1.25M | Sell |
|
|||||
|
2022
Q4 | $7.27M | Sell |
|
|||||
|
2022
Q3 | $8.21M | Buy |
|
|||||
|
2022
Q2 | $231K | Sell |
|
|||||
|
2022
Q1 | $2.94M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.27M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.63M | Buy |
|
|||||
|
2020
Q3 | $362K | Sell |
|
|||||
|
2020
Q2 | $1.17M | Buy |
|
|||||
|
2020
Q1 | $537K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.01M | Buy |
|
|||||
|
2019
Q2 | $660K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.64M | Sell |
|
|||||
|
2018
Q2 | $8.08M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $735K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $533K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $3M | Buy |
|